Molecular Interaction Atlas (MIA) |
|
Indication(s) of Apilimod |
Disease Entry |
ICD 11 |
Status |
REF |
Coronavirus Disease 2019 (COVID-19) |
1D6Y
|
Preclinical |
[2] |
|
|
Apilimod Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
HUMAN phosphatidylinositol 3-phosphate 5-kinase (PIKfyve)
|
TT0S3MP
|
FYV1_HUMAN
|
Inhibitor
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Indication(s) of Piperacetazine |
Disease Entry |
ICD 11 |
Status |
REF |
Schizophrenia |
6A20
|
Approved |
[3] |
|
|
Piperacetazine Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
Dopamine D2 receptor (D2R)
|
TTEX248
|
DRD2_HUMAN
|
Modulator
|
[4] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Piperacetazine Interacts with 1 DOT Molecule(s)
DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Potassium voltage-gated channel subfamily H member 2 (KCNH2)
|
OTZX881H
|
KCNH2_HUMAN
|
Decreases Activity
|
[5] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|